Search
⚲

Type	Result	AUM

Akari Therapeutics PLC
Firm
Fund #
CIK #	0001541157
Sale	2025-10-16 (6.2 M Offered, 6.2 M Sold)
Fund
Phone	9292747510
Address	401 East Jackson Street Tampa, Florida 33602
Source	[EDGAR]

Amount Raised ($M)

Company Details
Director
Custodian
Auditor
Marketer
Broker
Jurisdiction

Form D Offering
Filed	2025-10-24 (D)
Exemption	506(b)
Duration	One year or less
Commission	$180,000
Revenue	Decline to Disclose

In the News
Fri, 23 Oct 2026	Akari Therapeutics Plc Estimates – NASDAQ:AKTX — TradingView
Sat, 17 Oct 2026	Form 4 Akari Therapeutics PLC ADR: Abizer Gaslightwala (Director, CEO) For: 18 August — Investing.com Nigeria
Sat, 17 Oct 2026	Form 4 Akari Therapeutics PLC ADR: Hoyoung Huh (Director, 10% Owner) For: 18 August — Investing.com Canada
Thu, 15 Oct 2026	Akari Therapeutics, plc Advances Aktx-101 Toward Planned Phase 1 Clinical Development — www.marketscreener.com
Tue, 13 Oct 2026	Akari Therapeutics, Plc Announces Appointment of Vatnak Vat-Ho as Chief Business Officer — www.marketscreener.com

Directors	Role	2011 - 2026
Jim Neal	Director
Abizer Gaslightwala	Executive Officer
Rob Bazemore	Director
Kameel Farag	Executive Officer
Hoyoung Huh	Director
Ray Prudo	Director
Sandip Patel	Director
Samir Patel	Director

{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "stripe_subscribe": "/stripe-subscribe", "update_card": "/update-card"}

{"uid": 242677511, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}

False

360484443